Real-time enrollment status for this tardive dyskinesia clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT07105111 |
| Recruiting Status | Recruiting |
| Condition | Tardive Dyskinesia |
| Phase | PHASE4 |
| Target Enrollment | 100 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | September 18, 2026 (3 weeks ago) |
As of October 15, 2026: Clinical trial NCT07105111 is currently recruiting participants. This phase4 study for tardive dyskinesia is actively seeking new participants at 19 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07105111 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07105111 was last updated 3 weeks ago (September 18, 2026). HelloStudys verifies this status automatically.